Reuters
03 Jun 2026, 13:19 UTC · 2h ago
US FDA to review AI-based tool to predict drug-related liver damage

Search tags
Reuters
03 Jun 2026, 13:19 UTC · 2h ago

Search tags
Story key points
1 claims · impact-rated
The FDA has accepted a letter of intent for an AI-based tool designed to predict drug-induced liver injury. — Integrating AI into the drug development pipeline could significantly reduce clinical trial failure rates and lower R&D costs for pharmaceutical companies.
+0.40Ticker attribution
Model heads
No ticker sentiment head found.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Browse live screeningsImpact vectors
4 dimensions · 9 clusters
Continue reading
6 related stories
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Fox Business
3h ago

Zacks Investment Research
1h ago